Over the Counter

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

Jesse Dresser, Esq, joined Over the Counter to provide necessary insights into recently signed PBM reform set to revolutionize the distribution of pharmacy benefits.

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

Chad Worz, PharmD, BCGP, FASCP, and James Lewis, from the American Society of Consultant Pharmacists (ASCP), joined Over the Counter to discuss the Inflation Reduction Act's industry-wide changes kicking off in 2026.

Meagan Brown, PharmD, BCACP, joined Over the Counter to celebrate National Pharmacist Day and discuss the various avenues for expanding pharmacists' scope.

Susan Thomas, RN, joined Over the Counter to discuss women's health, the pharmacist's role, and her organization's newly launched program designed to benefit both patients and providers.

Jennifer Flynn, CPHRM, joined Over the Counter to discuss pharmacists' potential risks and benefits when using social media for professional or personal purposes.

Kenric B. Ware, PharmD, MBA, AAHIVP, joined Over the Counter to discuss stigmas surrounding HIV care and prevention as well as the pharmacist's role in advancing management of the condition.

Ron Lanton III, Esq, joined Over the Counter to discuss the Most Favored Nation drug pricing policy and what exactly it may mean for stakeholders heading into 2026.

Megan Smith, PharmD, joined Over the Counter to discuss continuously updated pneumococcal vaccines and the pharmacist's role among the greater health care community in managing pneumococcal diseases.

John C. Goodman, PhD, joined Over the Counter to discuss TrumpRx and this presidential administration's plans for lowering drug prices in the years to come.

Catie Stimmel, PharmD, joined Over the Counter to discuss the importance of patient safety organizations for the greater health care continuum.

Rick Sage, executive vice president of innovation and standards at NCPDP, joined Over the Counter to discuss the lasting impacts of the government shutdown on pharmacy and how it affected industry processes heading into 2026.

Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, joined Over the Counter to discuss both state and federal PBM reform heading into the new year.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, joined Over the Counter to discuss pharmacists' roles in improving diabetes outcomes as well as reaching patients in their communities.

Alyssa Mack, PharmD, joined Over the Counter during American Pharmacists Month to discuss how her pharmacy practice has put a focus on increasing clinical services.

Steve Moore, PharmD, joined Over the Counter during American Pharmacists Month to discuss community pharmacy innovations, collaborations, and partnerships driving improved patient outcomes.

Brad Phillips, PharmD, BCACP, joined Over the Counter during American Pharmacists Month to discuss the evolution of pharmacy education amid a rapidly growing expansion of pharmacists' clinical authority.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, joined Over the Counter during American Pharmacists Month to discuss the increased use of technology in pharmacy practice.

Lissette Logan, PharmD, and Danielle Weaver, RPh, joined Over the Counter to discuss OvaryIt's PRISM platform and how it's helping pharmacists in rural communities provide contraceptive and family-planning services.

Bill Wolfe, COO of WriteWise, joined Over the Counter to discuss the current turning point in the PBM industry and how his company is leveraging technology to lower costs and improve care.

Rae McMahan joined Over the Counter to discuss her role at Prescryptive Health and the ways her organization is helping patients and providers navigate GLP-1 benefits.

Pooja Babbrah, executive vice president of strategy and industry alignment at NCPDP, discusses how her organizations' standards are making a meaningful difference in the pharmacy industry.

Chris Bell, JD, vice president of business operations at API Warehouse, discusses DSCSA compliance and fraudulent threats to community pharmacy practices.

Andrew Maiorini, PharmD, FAHM, joined Over the Counter to discuss the importance of education and patient engagement when it comes to the pharmacist's role in addressing medication adherence.

Calvin Hunsicker, founder & chief product officer at SureCost, discusses ongoing pharmacy procurement challenges in 2025 and how his company is helping businesses tackle these obstacles.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, joined Over the Counter to discuss her role in drafting new guidelines that help bolster the authority of critical care pharmacists across the country.

Bil Schmidtknecht joined Over the Counter to discuss how his son Cole's tragic story led to a change in career paths focused on advocating for patients.

Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss how pharmacy turnover rates impact independents, chains, and the patients they serve.

Samantha Picking, PharmD, joined Over the Counter to discuss her role as Walgreens' senior director of immunizations during National Immunization Awareness Month.

Ashley Kay Pendrick, PharmD, joined Over the Counter to discuss her work with Prosper Rx Consulting and how pharmacists have more opportunities than ever to step out of their comfort zones within the profession.

Hashim Zaibak, PharmD, joined Over the Counter to discuss the overall role of pharmacists in administering vaccines and how community pharmacies in particular have stepped up in a big way.

Michael Murphy, PharmD, MBA, joined Over the Counter to discuss the growing concerns surrounding pharmacy deserts that are spanning across thousands of communities in the US.

Michael Kleinrock, lead research director at IQVIA, joined Over the Counter to discuss the importance of his company's Understanding the Use of Medicines in the US 2025 report.

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

Brett Barker, PharmD, joined Over the Counter to discuss Iowa's recent signing of PBM reform and what it might mean for pharmacies and other states looking to enact similar legislation.

Jon Easter, RPh, joined Over the Counter to discuss the main ideas of his presentation from the American Diabetes Association's 85th Scientific Sessions.

Rick Gates, chief pharmacy officer at Walgreens, joined Over the Counter to discuss the current state of retail pharmacy and the ongoing events that have impacted it.

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, joined Over the Counter to discuss key takeaways in their organization's 2025 Trends in Drug Benefit Design Report.

Amina Abubakar, PharmD, AAHIVP, joined Over the Counter to discuss her career journey within the pharmacy profession, from her time in big-box retail to owning an independent pharmacy and continuing education institute.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Over the Counter to discuss the potential impact pharmaceutical tariffs may have on pharmacies if they are to be widely implemented in the near future.

David Swenson, RPh, joined Over the Counter to discuss the new drug shortage technology, CCT Rx Shortage Solutions, his company is helping bring to pharmacies across the country.

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis A and B vaccines and the ways in which pharmacists can play their role in boosting vaccine uptake and reducing hesitancy.

Vin Gupta, MD, joined Over the Counter to discuss the future of the pharmacy profession and how digitally innovative solutions can lead to advanced patient care as well as growth in the role of pharmacists.

Antonio Ciaccia joined Over the Counter to discuss pharmacy benefit managers, their role within the pharmaceutical supply chain, and how that role has evolved over time. 

Luke Turnock, PhD, joined Over the Counter to discuss the increase of lifestyle enhancement drug use on social media, the internet cultures that are fueling the use of these drugs, and how it may impact potential consumers.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Over the Counter to discuss common trends, challenges, and the importance of pharmacists in managing OTC medications for pain treatment.

David Blair, CEO of independent pharmacy benefit manager LucyRx, joined Over the Counter to discuss his company's innovative reimbursement model and they are working to revolutionize the pharmacy benefits market.

Jenny Markell, BA, joined Over the Counter to discuss her extensive research into direct-to-consumer advertising of prescription drugs and how it may misinform potential patients.